Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Winthrox Laboratories Pvt. Ltd

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000807 121 linked products · source seen 10 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx121product presentations
G44generic molecules
DF8dosage-form groups
TA13therapeutic areas
PKR121current price records
REG84registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage89%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixWinthrox Laboratories Pvt. LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026Anti-infectives57 · 47%CNS & mental health20 · 17%Vitamins, minerals & nutrition15 · 12%Fluids & supportive care7 · 6%Gastrointestinal & hepatology6 · 5%Pain & musculoskeletal5 · 4%Dermatology2 · 2%Other therapeutic areas9 · 7%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioWinthrox Laboratories Pvt. LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026121presentationsTablet39 · 32%Injection33 · 27%Suspension15 · 12%Syrup10 · 8%Drops8 · 7%Capsule7 · 6%Other forms9 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionWinthrox Laboratories Pvt. LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026108comparable productsBelow market median44 · 41%Near market median19 · 18%Above market median45 · 42%Company median price position+3.7%Lowest-price equivalents12Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsWinthrox Laboratories Pvt. LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/winthrox-laboratories-pvt-ltdGenerated 10 Aug 2026Pharmasol (Pvt) Ltd.31 shared70% overlapM/s. Genix Pharma (Pvt) Ltd.28 shared64% overlapMediate Pharmaceutical Pvt Ltd28 shared64% overlapBio-Labs(Pvt) Ltd28 shared64% overlapNeutro Pharma (Pvt.) Ltd.,28 shared64% overlapMacter International Limited26 shared59% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives57 products · 47%
CNS & mental health20 products · 17%
Vitamins, minerals & nutrition15 products · 12%
Fluids & supportive care7 products · 6%
Gastrointestinal & hepatology6 products · 5%
Pain & musculoskeletal5 products · 4%
Dermatology2 products · 2%
Hematology & thrombosis2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antiepileptics20 products · 17%
Third-generation cephalosporins17 products · 14%
Vitamins / minerals / hematinics15 products · 12%
Macrolide antibacterials12 products · 10%
Antimalarials10 products · 8%
Fluoroquinolone antibacterials8 products · 7%
Fluids, electrolytes & diluents7 products · 6%
Analgesics / NSAIDs5 products · 4%
Formulation footprint

Dosage forms

Tablet39 products
Injection33 products
Suspension15 products
Syrup10 products
Drops8 products
Capsule7 products
Solution5 products
Sachet4 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 LivilipLevetiracetam 10presentations 100 mg/mL, 250 mg, 500 mg, 500 mg/5 mL · Solution, Tablet, Injection #2 WapivalDivalproex sodium 8presentations 250 mg, 500 mg · Tablet #3 AudyCeftriaxone 6presentations 1000 mg, 2 g, 250 mg, 500 mg · Injection #4 WinkidofenIbuprofen 5presentations 100 mg/5 mL, 200 mg/5 mL · Syrup, Suspension #5 WintekClarithromycin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #6 WintermArtemether + Lumefantrine 5presentations 40 mg + 240 mg, 80 mg + 480 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median4441% of comparable products
Near market median19within ±5% of median
Above market median4542% of comparable products
Lowest-price equivalents12ties included
Company median price position +3.7% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Livilip 500 mg/5 mLLevetiracetam · Injection · 5ml x10's PKR 68.97/mL-47.0% vs market median Livilip 100 mg/mLLevetiracetam · Oral solution · 120ml PKR 7.32/mL-45.3% vs market median Livilip 100 mg/mLLevetiracetam · Oral solution · 60ml PKR 7.32/mL-45.3% vs market median Livilip 500 mgLevetiracetam · Tablet · 30's PKR 53.06/tablet-43.6% vs market median Livilip 100 mg/mLLevetiracetam · Oral solution · 30ml PKR 7.73/mL-42.3% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Pharmasol (Pvt) Ltd.251 products · 101 generics 31shared generics M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 28shared generics Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 28shared generics Bio-Labs(Pvt) Ltd234 products · 82 generics 28shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 28shared generics Macter International Limited248 products · 91 generics 26shared generics
Regulatory & price activity

Observed database signals

Registration numbers84
Price-history records153
Products with price history23
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date7 Aug 2026
Latest source observation10 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

57 results
Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Wintek Clarithromycin 125 mg/5 mL Dry suspension 30 ml 079695 PKR 227.16 PKR 7.57/mL Near median
Wintek Clarithromycin 250 mg/5 mL Dry suspension 70 ml 074944 PKR 898.20 PKR 12.83/mL 14% above median
Wintek Clarithromycin 250 mg Tablet 10's 086752 PKR 501.32 PKR 50.13/tablet 8% above median
Wintek-XL Clarithromycin 500 mg Tablet 5's 074930 PKR 427.48 PKR 85.50/tablet Near median
Wintek-XL Clarithromycin 500 mg Extended-release tablet 1's 074930 PKR 92.93 PKR 92.93/tablet 14% above median
Winterm Artemether + Lumefantrine 40 mg + 240 mg Tablet 10's 100493 PKR 559.13 PKR 55.91/tablet 12% below median
Winterm Artemether + Lumefantrine 80 mg + 480 mg Tablet 1 x 8's 100494 PKR 689.31 PKR 86.16/tablet 21% below median
Winterm Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 100493 PKR 421.08 PKR 52.64/tablet 18% below median
Winterm Artemether + Lumefantrine 80 mg + 480 mg Tablet 2 x 8's 100494 PKR 1,309.69 PKR 81.86/tablet 25% below median
Winterm Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 100494 PKR 399.20 PKR 66.53/tablet 39% below median
Zever Cefixime 400 mg Capsule 5's 091088 PKR 591.98 PKR 118.40/capsule Near median
Zever Cefixime 100 mg/5 mL Dry suspension 30ml 091096 PKR 330.36 PKR 11.01/mL 5% above median
Zever Cefixime 200 mg/5 mL Dry suspension 30ml 091095 PKR 404.28 PKR 13.48/mL Near median
Zever Cefixime 200 mg Capsule 1x5's 100495 PKR 378.55 PKR 75.71/capsule 21% above median
Zidor Azithromycin 200 mg/5 mL Suspension 15 ml 074945 PKR 345.45 PKR 23.03/mL 8% above median
Zidor Azithromycin 250 mg Capsule 10'S 074943 PKR 533.88 PKR 53.39/capsule 10% above median
Zidor Azithromycin 500 mg Tablet 6's 086794 PKR 594.61 PKR 99.10/tablet 17% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.